Article

The Association between Cigarette Smoking and Efavirenz Plasma Concentration using the Population Pharmacokinetic Approach

2020-11-30

Abstract excerpt

<h4>Aim: </h4> Efavirenz is still widely used as the preferred first-line antiretroviral agent in the middle- and low- income countries, including Malaysia. The efavirenz population pharmacokinetic profile among HIV-positive smokers is still unknown. We aimed to assess the association of smoking with efavirenz and the differences in HIV clinical outcomes. <h4>Methods:</h4> A total of 154 stable HIV-positive patien...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5210b596-804c-536d-a7ba-da38cef066c6
DOI: 10.22541/au.160622302.27663338/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The Association between Cigarette Smoking and Efavirenz Plasma Concentration using the Population Pharmacokinetic ApproachDOI 10.22541/au.160622302.27663338/v2Read

Population Approach to Efavirenz Therapy.Semantic proximity Read

Population pharmacokinetics of nevirapine in Malaysian HIV patients: a non-parametric approach.Semantic proximity Read

Dose Optimization of Efavirenz Based on Individual CYP2B6 Polymorphisms in Chinese Patients Positive for HIV.Semantic proximity Read

How has the prevalence of smoking cigarettes among HIV-infected patients changed over the last decade? Single-center analysisSemantic proximity Read

Population pharmacokinetic/pharmacogenetic model for optimization of efavirenz therapy in Caucasian HIV-infected patients.Semantic proximity Read

Dosage Optimization of Efavirenz Based on a Population Pharmacokinetic-Pharmacogenetic Model of HIV-infected Patients in Thailand.Semantic proximity Read

Population Pharmacokinetic Model Linking Plasma and Peripheral Blood Mononuclear Cell Concentrations of Efavirenz and Its Metabolite, 8-Hydroxy-Efavirenz, in HIV Patients.Semantic proximity Read

Pharmacogenetics-based population pharmacokinetic analysis of efavirenz in HIV-1-infected individuals.Semantic proximity Read

Effects of Smoking on Pegylated Interferon alpha 2a and First Generation Protease Inhibitor-based Antiviral Therapy in Naïve Patients Infected with Hepatitis C Virus Genotype 1.Semantic proximity Read

Estimates of Prevalence, Time-Trend, and Association of Smoking in Adults Living with HIV, HBV, and HCV (NHANES 1999–2018)Semantic proximity Read

Influence of the cytochrome P450 2B6 genotype on population pharmacokinetics of efavirenz in human immunodeficiency virus patients.Semantic proximity Read

Pharmacogenomics and pharmacokinetics of efavirenz 400 or 600 mg in 184 treatment-naive HIV-infected patients in China.Semantic proximity Read